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Avian influenza A viruses often do not propagate efficiently in mammalian cells. The viral
polymerase protein PB2 is important for this host restriction, with amino-acid polymorphisms at
residue 627 and other positions acting as ‘signatures’ of avian- or human-adapted viruses.
Restriction is hypothesized to result from differential interactions (either positive or inhibitory) with
unidentified cellular factors. We applied fluorescence recovery after photobleaching (FRAP) to
investigate the mobility of the viral polymerase in the cell nucleus using A/PR/8/34 and A/Turkey/
England/50-92/91 as model strains. As expected, transcriptional activity of a polymerase with the
avian PB2 protein was strongly dependent on the identity of residue 627 in human but not avian
cells, and this correlated with significantly slower diffusion of the inactive polymerase in human but
not avian nuclei. In contrast, the activity and mobility of the PR8 polymerase was affected much
less by residue 627. Sequence comparison followed by mutagenic analyses identified residues at
known host-range-specific positions 271, 588 and 701 as well as a novel determinant at position
636 as contributors to host-specific activity of both PR8 and Turkey PB2 proteins. Furthermore,
the correlation between poor transcriptional activity and slow diffusional mobility was maintained.
However, activity did not obligatorily correlate with predicted surface charge of the 627 domain.
Overall, our data support the hypothesis of a host nuclear factor that interacts with the viral
polymerase and modulates its activity. While we cannot distinguish between positive and
inhibitory effects, the data have implications for how such factors might operate.
INTRODUCTION
The natural reservoir of influenza A viruses is waterfowl,
but a wide range of avian and mammalian hosts can be
infected (Webster et al., 1992). Influenza strains adapt to a
specific host, and only rarely does a virus infect and
transmit efficiently in a new species. For humans, this last
happened in 2009, with a swine-origin virus that initiated
the first pandemic of the 21st century (Taubenberger &
Kash, 2010). Since 1997, H5N1 avian influenza viruses have
caused sporadic, severe infections in man. However,
sustained human transmission resulting in a ‘bird-flu’
pandemic has not yet occurred, for reasons that are unclear
but presumably reflect the difficulty of successfully crossing
the species barrier.
Influenza A virus has a negative-stranded RNA genome
whose eight vRNA segments encode up to 12 proteins
(Wise et al., 2009). The virus encodes its own RNA-
dependent RNA polymerase, which transcribes and repli-
cates the virus genome (Neumann et al., 2004). The
polymerase complex (3P) is a heterotrimer of PA, PB1 and
PB2 which, together with vRNA and NP, forms a
ribonucleoprotein (RNP) complex (Portela & Digard,
2002). PB1 is the polymerase, while PB2 binds the cap
structures of cellular pre-mRNAs, which are then cleaved
off through PA endonuclease function to prime viral
mRNA synthesis (Boivin et al., 2010). RNA synthesis takes
place in the cell nucleus and involves multiple interactions
with cellular molecules that act as both positive and
negative factors for the overall process of virus replication
(Josset et al., 2008). It is plausible that some of these
interactions contribute to host specificity and, consistent
with this, much genetic evidence implicates the virus
polymerase in defining host range (HR) (Naffakh et al.,
2008).
In particular, PB2 has long been known to play an
important role in setting host specificity (Almond, 1977).
Subsequent work showed that an avian virus could gain
replication competence in mammalian cells through
changing a single amino acid at position 627 of PB2
(Subbarao et al., 1993). This has since been confirmed for
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many virus strains in cell culture and laboratory animals, as
well as correlating with human disease (Hatta et al., 2001;
Le et al., 2009; Munster et al., 2007; Naffakh et al., 2008).
Until recently, most human viruses possessed a lysine (K)
at position 627, while avian viruses have glutamic acid (E)
(Chen et al., 2006; Finkelstein et al., 2007; Miotto et al.,
2008). However, PB2 627K is not obligatory for efficient
infection or disease induction in mammals. Exceptions to
the ‘627 rule’ include equine influenza viruses, some swine
viruses, certain avian H5N1 isolates and, most notably, the
2009 pandemic virus, all of which have PB2 627E (Gao
et al., 1999; Schnitzler & Schnitzler, 2009; Shinya et al.,
2007). Indeed, engineering a 627K change into the 2009
pandemic virus did not result in increased virulence
(Herfst et al., 2010; Jagger et al., 2010; Zhu et al., 2010).
In such cases, other residues within PB2 contribute to
adaptation to replication in mammalian cells; such poly-
morphisms include T271A, A588I, GQ590/591SR, Q591K,
D701N, S714R and probably others (Bussey et al., 2010;
Gabriel et al., 2005; Li et al., 2005, 2009; Mehle & Doudna,
2008, 2009; Naffakh et al., 2000; Yamada et al., 2010; Yao
et al., 2001).
The mechanism(s) by which alterations to the PB2 sequence
extend HR is uncertain. Poor replication in mammalian cell
culture is often correlated with low polymerase activity,
especially in ‘minireplicon’ assays that measure viral trans-
cription indirectly (Gabriel et al., 2005; Labadie et al., 2007;
Massin et al., 2001; Munster et al., 2007; Naffakh et al.,
2000; Yao et al., 2001). This plausibly reflects functionally
important sequence-dependent interactions between PB2
and a cellular factor. Consistent with this, structural analysis
of the C-terminal region of PB2 shows that residue 627 is
surface exposed and that the E/K polymorphism makes a
large difference to the charge of the domain face (Kuzuhara
et al., 2009; Tarendeau et al., 2008). However, the identity of
the putative HR-defining cellular protein(s) is unknown
and, although many interaction partners of the viral
polymerase have been identified, to date there are no
reports of any that show 627E/K dependency. A nuclear
localization signal (NLS) subdomain at the very C terminus
of PB2 contains the HR-specific residues 701 and 714
(Mukaigawa & Nayak, 1991; Tarendeau et al., 2007), and
there is evidence of host-specific interactions with some
importin a isoforms (Boivin & Hart, 2011; Gabriel et al.,
2008; Resa-Infante et al., 2008). However, it is not clear that
this mechanism explains the role of residue 627. Further
confounding the issue, studies utilizing fusions of human
and avian cells have come to conflicting conclusions about
how the putative 627-dependent interaction affects poly-
merase function. One study favoured a human cell
inhibitory factor that interacts with a 627E polymerase
(Mehle & Doudna, 2008), while another proposed an
activating factor that only acts on the 627K polymerase
(Moncorge´ et al., 2010).
Here, we applied the live cell microscopy system recently
established in our laboratory (Loucaides et al., 2009) to
investigate the effects of PB2 HR mutations on the nuclear
dynamics of the viral polymerase. In support of the
existence of a mammalian-specific interaction partner, we
find that PB2 polymorphisms affect the dynamics of the
viral polymerase in living cells, with low polymerase
activity correlating with slow diffusional mobility. These
data have implications for future strategies to identify the
host factors involved.
RESULTS
cDNA clones from two virus strains were used to
investigate the effects of PB2 HR mutations on the
dynamics of the viral polymerase: A/PR/8/34 (PR8), a
laboratory-adapted human isolate that retains mammalian
signature residues at a majority of known loci (de Wit
et al., 2004; Fields & Winter, 1982), and A/turkey/England/
50-92/91 (50-92), a highly pathogenic avian influenza virus
that replicates poorly in mammalian cells and whose PB2
(hereafter, tPB2) has avian signature sequences (Howard
et al., 2007; Moncorge´ et al., 2010; Wood et al., 1993). For
both PB2 clones, ‘avianizing’ or ‘humanizing’ mutations
were introduced into position 627, producing the set of
PB2 variants PR8 wt, PR8 627E, tPB2 wt and tPB2 627K.
First, the influence of position 627 on viral polymerase
activity was tested in minireplicon assays in human 293T
and avian QT35 cells. PR8 PB1, PA, NP and the various
PB2 plasmids were cotransfected with a plasmid expressing
a synthetic vRNA encoding luciferase (under either a
mammalian or avian RNA pol I promoter as appropriate)
to reconstitute RNPs. Wild-type PR8 RNPs resulted in a
high luciferase readout in both 293T and QT35 cells, while
omitting PB2 reduced luciferase levels by 3 log10 to
background values (Fig. 1a). Replacing PR8 PB2 with
tPB2 decreased the activity of the viral polymerase several
hundredfold in 293T cells while, in QT35 cells, the decrease
was less than tenfold. Introducing the humanizing 627K
mutation into tPB2 recovered polymerase activity to close
to PR8 wt levels in both cell types. In contrast, introducing
the avianizing 627E change into PR8 PB2 had little effect
on polymerase activity in either cell type. Similar overall
outcomes were obtained when the experiments were
repeated in human HeLa and avian DF1 cells, as well as
when RNPs were reconstituted using an authentic segment
8 vRNA or with GFP-tagged PB1 or PA subunits (data not
shown). Therefore, while the single amino acid change in
tPB2 had a major impact on viral transcription in human
but not avian cells (as seen previously; Massin et al., 2001;
Moncorge´ et al., 2010), the introduction of the avian 627E
residue in PR8 did not recapitulate this. The cell type- and
position 627-dependency of tPB2 activity in the back-
ground of an otherwise PR8 RNP also indicates that there
is no fundamental incompatibility between the avian PB2
and the mammalian-origin PB1, PA and NP proteins.
To test whether impaired transcription by tPB2 was a result
of defective nuclear import in 293T cells, PB2 localization
was examined by immunofluorescence. However, all PB2
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variants localized efficiently to the nucleus of both 293T
and QT35 cells, with no observable differences in staining
pattern resulting from altering residue 627 (Fig. 1b). To
test whether impaired polymerase function resulted from
an inability to form 3P complexes in human cells, tandem
affinity purification (TAP)-tagged purification assays were
performed, where PB1–TAP (Engelhardt et al., 2005), PA
and the various PB2 constructs were transfected and cells
were radiolabelled for 6 h at 24 h post-transfection. TAP-
tagged complexes were purified on IgG Sepharose beads
and cleaved off with TEV protease before analysis by SDS-
PAGE. Similar amounts of PB1 and PA/PB2 were detected
by autoradiography and, when Western blots for PB2 were
performed, no obvious differences in 3P complex forma-
tion were observed (Fig. 1c).
Having validated the system, we applied the live cell micro-
scopy technique of fluorescence recovery after photo-
bleaching (FRAP) to examine the mobility of the viral
polymerase complex in the nucleus of transfected cells. The
hypothesis that restriction of polymerase complexes with
an avian-like PB2 in 293T cells results from differential
interactions with a mammalian host factor might be pre-
dicted to result in 627-dependent variations in polymerase
dynamics. Accordingly, 3P complexes were reconstituted in
cells by expressing PB1–GFP together with PA and the
various PB2 proteins in either 293T or QT35 cells. When
FRAP analyses were performed in 293T cells, as shown
previously (Loucaides et al., 2009), an incomplete poly-
merase complex consisting of only PB1 and PA showed
rapid and almost complete recovery kinetics from the
bleach phase, while the inclusion of PR8 wt PB2 resulted in
a marked increase in the immobile fraction, as defined by
the recovered fluorescence reaching a plateau at less than
100% of the starting value (Fig. 2a; Table 1). The kinetics
of this incomplete recovery also showed a marked decrease
in the diffusion coefficient (DC) of the trimeric polymerase
(Fig. 2b; Table 1). A similar pattern of significantly slower
diffusion and increased immobile fraction of the complete
3P complex compared with the 2P dimer was obtained
when the experiments were performed in avian QT35 cells
(Fig. 2c, d), although the mobility of the PB1–GFP–PA
dimer was slower in the avian cells than in the mammalian
cells (Table 1). When PR8 PB2 was replaced by tPB2, the
DC of the polymerase in 293T cells showed a significant
decrease of nearly twofold compared with the mammalian-
adapted polymerase, and the immobile fraction increased
to over a quarter of the total population (Fig. 2a, b; Table
1). However, altering residue 627 in tPB2 to lysine
significantly increased polymerase complex diffusion and
reduced the immobile fraction to levels closer to the PR8
wt complex. ‘Avianizing’ PR8 PB2 with a 627E change had
less effect on polymerase dynamics than complete replace-
ment with tPB2, causing an increase in the immobile
fraction and a decrease in the DC that was not statistically
significant in comparison with the parental complex. When
tested in avian QT35 cells, neither of the paired E627K
changes altered mobility of the polymerase significantly
(Fig. 2c, d; Table 1). Similar overall outcomes were
obtained when the dynamics of PR8, tPB2 and tPB2
627K complexes were examined using PA–GFP in place of
PB1–GFP (data not shown). Thus, the intranuclear dyna-
mics of the viral polymerase complex correlate with
transcriptional activity, with the identity of PB2 627
strongly affecting both measures when tPB2 was assessed
in mammalian but not avian cells, and having less effect on
the PR8 PB2 subunit. This is consistent with the hypothesis
that the nature of residue 627 of an avian virus PB2
differentially affects protein–protein interactions in the
nucleus of human cells.
To confirm expression of the viral proteins, Western blots
were performed on cells after FRAP analysis and levels were
found to be similar between the samples (Fig. 2e). To test
the potential significance of small fluctuations in PB2 levels
on the mobility of the polymerase complex, we titrated PR8
wt PB2 in the presence of constant amounts of PB1–GFP
and PA. Western blot analysis confirmed that transfec-
tion of increasing amounts of PB2 plasmid resulted in
increasing accumulation of the polypeptide (Fig. 2f, inset).
Parallel FRAP analysis showed that even the smallest
amount of PB2 resulted in the characteristic drop in
Fig. 1. Functional characterization of PB2 627 variants. (a)
Minireplicon activity assays were performed at 48 h in 293T (open
bars) or QT35 (filled bars) cells. Readings were normalized (%) to
PR8 wt PB2 levels. Values plotted are means±SEM (n56–8). (b)
293T or QT35 cells were transfected with the indicated PB2
protein, fixed at 24 h and stained for PB2 in green; DAPI (blue)
was used to stain nuclei. (c) SDS-PAGE and Western blot (top
panel) and autoradiography (bottom panel) analysis of polymerase
complexes purified over IgG-Sepharose. 293T cells were trans-
fected as indicated with PB1–TAP (or untagged PB1; ‘no TAP’
lane), PA and PB2 and labelled with 35S-Met for 6 h at 24 h post-
transfection before purification.
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Fig. 2. FRAP analysis of PB2 627 variants. (a, c) Average FRAP recovery curves of 3P complexes tagged with PB1–GFP in
293T cells (a) or QT35 cells (c) are plotted. (b, d) Mean±SEM DC values measured in 293T (b) or QT35 (d) cells. Braces
indicate significance tests: ns, non-significant; *, P,0.05; **, P,0.01; ***, P,0.001. (e) 293T samples were analysed by
Western blotting for GFP, PA or PB2. (f) 293T cells were transfected with PB1–GFP, PA and the indicated amounts of PB2
plasmid (as fold difference from the other P proteins, with ‘1’ indicating 500 ng) and analysed by FRAP and (inset) Western
blotting for PB2. The curve fit (r250.95) is for a one-site binding model.
Table 1. Effect of varying PB2 on the nuclear dynamics of the influenza virus polymerase
The ‘Background’ column identifies the strain background and the identity of position 627, while the ‘Further mutations’ column indicates the
presence or absence of further mutations. ND, Not done.
PB2 plasmid 293T QT35
Background Further
mutations
DC (mm2 s”1)
(mean±SEM)
Immobile fraction
(mean±SEM)
n (N)* DC (mm2 s”1)
(mean±SEM)
Immobile fraction
(mean±SEM)
n (N)*
2PB2 – 0.68±0.05 0.01±0.01 31 (3) 0.49±0.05 0±0.03 46 (5)
PR8 wt 0.26±0.03 0.18±0.02 29 (3) 0.23±0.02 0.11±0.02 43 (5)
588 636 701 0.20±0.03 0.20±0.02 29 (3) ND ND ND
PR8 627E wt 0.20±0.02 0.20±0.01 26 (3) 0.25±0.03 0.17±0.02 31 (3)
588 636 701 0.14±0.01 0.25±0.02 31 (3) ND ND ND
tPB2 wt 0.14±0.01 0.26±0.02 17 (2) 0.23±0.02 0.16±0.02 47 (5)
588 636 701 0.16±0.01 0.26±0.01 31 (3) ND ND ND
tPB2 627K wt 0.20±0.02 0.21±0.01 25 (3) 0.21±0.02 0.19±0.02 46 (5)
588 636 701 0.35±0.02 0.12±0.01 32 (3) ND ND ND
*Total number of cells analysed from (in parentheses) the indicated number of independent transfections.
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diffusional mobility of the PB1–GFP–PA dimer and that
there was essentially no change in the DC over a close to
tenfold range of plasmid dose (Fig. 2f). Thus, PB2
concentrations were not limiting and the FRAP therefore
reflected intrinsic differences in the interactions of the PB2
variants, rather than small fluctuations in PB2 levels.
Further HR-defining residues in PB2
While the polymerase activity of the avian tPB2 in 293T
cells exhibited a marked dependency on residue 627,
introducing the 627E mutation into PR8 PB2 had only a
minor effect (Fig. 1a). We therefore investigated whether
other amino acid positions in the PB2 proteins affected
their activity in a host-specific manner. Aligning tPB2 with
PR8 PB2 revealed 24 differences (not shown) including, in
addition to the E627K polymorphism, several other
residues previously implicated by bioinformatics as avian/
mammalian host-specific signatures (Chen et al., 2006;
Finkelstein et al., 2007; Miotto et al., 2008; Naffakh et al.,
2000). We chose a subset of these residues spread through-
out the protein (summarized in Fig. 3a) for mutagenic
analysis: A199S, T271A, L475M, R526K, A588I and D701N.
We also investigated the L636F polymorphism, as it lies
near the base of the loop structure that contains residue
627 and the helix where HR-related residues 588, 590 and
591 lie (Fig. 3b). Mutations were introduced into PR8 PB2,
tPB2 and tPB2 627K backgrounds and the polypeptides
were tested in minireplicon assays in 293T and QT35 cells.
Western blot analysis confirmed expression of the proteins
in 293T cells, although some of the point mutations caused
slight mobility changes in the tPB2 polypeptides (Fig. 4a, b).
Fig. 3. Location of PB2 HR-determining residues. (a) Linear representation of PB2 showing regions with structural information
(shaded ovals: Guilligay et al., 2008; Kuzuhara et al., 2009; Sugiyama et al., 2009; Tarendeau et al., 2007) and the location of
sequence polymorphisms between PR8 PB2 and tPB2 (black lines5tested, blue lines5non-tested). (b) Two views of a ribbon
structure of the PR8 627 domain (3CW4 in PDB) with the side chains of mutated residues here shown in red. The 627 loop is
green and the helix it encircles is blue. The side chains of residues G590 and Q591 are yellow. (c) Surface electrostatic
potential modelling (using Swiss-Prot: red indicates negative charge, blue positive charge) on the 627 domain of PR8 or tPB2
(adapted from PDB 3L56; Yamada et al., 2010). Large arrowheads indicate the 627 patch, small arrowheads the 701 patch.
Values underneath are minireplicon activity in 293T cells.
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Mutating PR8 PB2 had little effect on transcriptional
activity in either mammalian or avian cells, making no
more than a twofold difference (Fig. 4c, d). In contrast,
humanizing tPB2 at positions 271, 588, 636 or 701 showed
partial compensation for the lack of 627K in an otherwise
fully avian PB2 in human cells, with changes at 636 and
701 increasing activity more than tenfold (Fig. 4c).
However, these mutations also substantially increased the
transcriptional activity of tPB2 in QT35 cells, although
here, position 271 had the greatest effect (Fig. 4d). The
199, 271, 588, 636 and 701 changes also showed additive
improvements in the transcriptional activity of tPB2 627K
in QT35 cells, but only the 271 change had a substantial
effect in mammalian cells. Thus, ‘humanizing’ changes to
several of the potential HR-determining residues in tPB2
modulated its activity, albeit often (by smaller amounts) in
avian as well as mammalian cells. However, ‘avianizing’
PR8 at these positions had little effect.
The 588, 636 and 701 polymorphisms are all in the 627/NLS
domain of PB2 (Fig. 3), and we therefore investigated
whether they exerted their effects synergistically, perhaps
compensating for 627E in mammalian cells. Accordingly, the
mutations were combined on the four backgrounds of PR8
wt, PR8 627E, tPB2 and tPB2 627K, before testing in
minireplicon assays in human and avian cells. Parallel
Western blot analysis confirmed that all polypeptides were
expressed in 293T cells, with only minor variations in level
(Fig. 5a, b). Even in combination, the additional mutations
had relatively small effects (less than tenfold) in 293T cells
when introduced onto a 627K background, either in PR8 PB2
or humanized tPB2 627K (Fig. 5c, e). They also had similarly
small effects on the function of either PB2 protein in QT35
cells irrespective of the identity of position 627 (Fig. 5d, f).
However, when tested in human cells on the background of
627E PB2, the additional mutations produced clear syn-
ergistic effects. Further avianizing PR8 627E with any of the
mutations at positions 588, 636 and 701 reduced transcrip-
tional activity nearly tenfold, while combining 636 with
either of the 588 or 701 changes produced a greater than
tenfold effect. Combining all four changes reduced PR8 PB2
activity in 293T cells almost to the level of wt tPB2.
Conversely, adding additional humanizing mutations onto a
tPB2 background incrementally increased polymerase activ-
ity in 293T cells even without the compensatory 627K
residue. A triple-mutant tPB2 with 588I, 636F and 701N
changes had activity more than a hundredfold greater than
that of the parental tPB2, reaching levels only fourfold lower
than PR8 wt PB2. Thus, PB2 amino acids 588, 636 and 701
also act as HR-defining residues that, together, compensate
for glutamic acid at position 627.
To investigate whether, like residue 627, these additional
PB2 HR mutations affected mobility of the polymerase
complexes in human cells, we investigated their dynamics in
293T cells with FRAP. Adding the triple avianizing muta-
tions onto either PR8 wt PB2 or PR8 627E caused slower
recovery of the polymerase complexes and an increase in the
size of the immobile fraction, to a point where the quadruple
PR8 mutant behaved identically to tPB2 (Fig. 6a, c; Table 1).
Adding the three humanizing mutations A588I, L636F and
D701N onto tPB2 did not alter the immobile fraction of the
polymerase complexes, but led to a slight increase in DC
Fig. 4. Expression and activity of PB2 HR mutants. (a, b) Western
blot analysis of 293T cells transfected with the indicated PB2
polypeptides (”, no plasmid; +, infected cell lysate). (c, d)
Minireplicon assay of HR mutants on PR8, tPB2 or tPB2 627K
backgrounds in 293T (c) or QT35 (d) cells. Values are normalized
to PR8 wt and dashed lines indicate this (upper) and tPB2 (lower)
levels. Means±SEM from at least three independent experiments
are plotted. RLU, Relative luciferase units.
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(Fig. 6b, c; Table 1). However, combining the humanizing
mutations with the already humanized tPB2 627K resulted
in a marked decrease of the immobile fraction and increase
in DC even compared with PR8 wt PB2. Western blot
analysis confirmed approximately equal levels of expression
of the viral polypeptides (Fig. 6d). Therefore, other HR
polymorphisms in the PB2 627 domain affect the dynamics
of the polymerase complex in human cells, with mutations
that reduce transcriptional activity in the context of an RNP
also reducing diffusional mobility of the 3P complex. To
explore the correlation between the two metrics, we plotted
polymerase minireplicon activities against DC for the HR
variants. Supporting a positive relationship between viral
gene expression and polymerase mobility, a straight line
fitted to the scatter plot showed a good correlation (r250.90;
Fig. 6e).
DISCUSSION
Many studies have shown that PB2 residue 627 plays an
important role in determining host restriction (Hatta et al.,
Fig. 5. Synergistic effects of 627 domain HR mutations. (a, b) Western blot analysis of 293T cells transfected with the indicated
PB2 polypeptides (”, no plasmid;+, infected cell lysate). (c–f) Minireplicon assay of HR mutants on PR8, PR8 627E, tPB2 or
tPB2 627K backgrounds in 293T (c, e) or QT35 (d, f) cells. Values are normalized to PR8 wt and dashed lines indicate this
(upper) and tPB2 (lower) levels. Means±SEM from at least three independent experiments are plotted.
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Fig. 6. FRAP analysis of combined 627 domain HR mutations. (a, b) Average FRAP recovery curves of 3P complexes tagged with
PB1–GFP in 293T cells for PR8 PB2 mutants (a) or tPB2 mutants (b). (c) Mean±SEM DC values measured in 293T cells. Braces
indicate significance tests: ns, non-significant; *, P,0.05; ***, P,0.001. (d) Cell lysates were analysed by Western blotting for
PB1, PA and PB2. (e) Scatter plot of diffusion coefficient versus minireplicon activity in 293T cells. The line shows a linear curve fit.
Host range and influenza A polymerase dynamics
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2001; Massin et al., 2001, 2010; Steel et al., 2009; Subbarao
et al., 1993), but the mechanism remains unclear. A
plausible hypothesis invokes a mammalian-specific inter-
acting protein, but it is controversial whether this is an
inhibitory factor that prevents a 627E-containing poly-
merase from operating properly (Mehle & Doudna, 2008)
or an important co-factor that only complements activity
of a 627K polymerase (Moncorge´ et al., 2010). Further-
more, 627-dependent binding of any cellular component
has yet to be demonstrated.
Here we show, using live cell microscopy, that the mobility of
the viral polymerase complex varies in human cells according
to the identity of PB2 627 and other HR-defining residues, in
correlation with transcriptional activity. This correlation
suggests that interactions of the viral polymerase with cellular
factors influence its activity. However, it seems unlikely that
slower polymerase mobility results directly from functional
impairment, because we measured the diffusional dynamics
under conditions where the enzyme is not active, lacking NP,
and, furthermore, diffusion of the polymerase in our FRAP
system is not affected by the presence of NP or RNP
formation (Loucaides et al., 2009). Also, the enzyme is active
when immobilized on a solid support (Lee et al., 2002, 2003).
Instead, it seems more plausible that the twin phenomena of
low activity and slow dynamics result from a common cause.
Based on prior reports of 627-dependent defects in inter-
actions between NP and the polymerase complex (Labadie
et al., 2007; Mehle & Doudna, 2008; Rameix-Welti et al.,
2009), we favour the hypothesis that low transcriptional
activity results from a failure to form RNPs effectively,
implying the involvement of host proteins in this assembly
process. Our data are also consistent with suggestions that
interactions between importin a and the NLS domain of PB2
affect the conformation and thus function of the polymerase
in a host-specific fashion (Boivin & Hart, 2011; Resa-Infante
et al., 2008).
At the extreme, two alternative explanations for the slower
diffusion of the less-active polymerase complexes can be
envisaged. Either a 3P complex containing an inactive avian
PB2 could be tightly bound to inhibitory cellular proteins that
are sufficiently large to explain the reduction in mobility (Fig.
7; ‘X’), or the polymerase is tethered to an immobile nuclear
component for longer periods than with a mammalian-
adapted PB2 and therefore slower movement is observed (Fig.
7; ‘static compartment’). Within this framework, the
hypothesis of an activating factor could envisage preferential
binding of the mammalian 3P to a soluble cellular protein
(Fig. 7; ‘Y’), which displaces another interaction to the static
compartment and/or a larger inhibitory protein. In either
case, the intermediate activities of PB2 proteins with changes
to other HR-defining residues would reflect intermediate
binding affinities. These hypotheses are not mutually
exclusive, and it is possible that more than one activity-
influencing host factor is involved. In agreement with
previous work (Rameix-Welti et al., 2009), however, we
found no difference in the ability of our PB2/627 variants to
bind cellular RNA polymerase II (data not shown).
While FRAP cannot distinguish between these hypotheses,
the changing mobilities we observed for the 3P complex
provide further experimental evidence for an interacting
factor(s) that is (are) dependent on PB2 627. The inter-
actions might be too transient to be detected readily in bio-
chemical assays, but strong enough to influence the mobility
and activity of the polymerase complexes. Our data and the
models suggested in Fig. 7 have implications for strategies to
identify the relevant interaction partners. The obvious route
for identifying soluble activating or inhibitory factors is
through examination of co-purifying proteins; here it may
be useful to compare polymerase complexes at the extremes
of activity and mobility, such as wt tPB2 and tPB2 mutated
at positions 588, 627, 636 and 701. The finding that low
activity correlates with slower mobility suggests that size-
based fractionation techniques might be useful for focusing
on an appropriate subpopulation of the viral polymerase. If
the polymerase interacts with a static component of the
nucleus, techniques adapted to deal with insoluble cellular
components could be worthwhile.
While PB2 627 can act as a signature of avian versus
mammalian viruses, some established mammalian viruses
have a 627E residue (Gao et al., 1999; Schnitzler &
Schnitzler, 2009; Shinya et al., 2007). Thus, while position
627 is often dominant, its importance is context depend-
ent. Altering 627 in tPB2 made a more than 250-fold
difference in 293T minireplicon activity, but had only a
twofold effect on PR8 PB2 activity (Fig. 1a). Mutagenizing
PR8 to resemble tPB2 and vice versa at positions 271, 588,
Fig. 7. Models for HR-dependent changes in nuclear diffusion.
Slow movement and low activity of 627E-containing polymerase
could result from increased interactions with a relatively large
soluble inhibitory cellular factor (‘X’) and/or with an insoluble ‘static
compartment’. Higher mobility and activity of a 627K polymerase
could result from decreased interactions with an inhibitor and/or
increased affinity for a soluble activating factor (‘Y’). Intermediate-
strength interactions occur with PB2 proteins containing com-
pensatory mutations at other HR-affecting positions.
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636 and 701 resulted in gradual convergence of the pheno-
types (Figs 4 and 5). In agreement with Bussey et al. (2010),
we found that altering positions 271 and 588 to the mam-
malian consensus improved polymerase activity. Residue
701 has been implicated previously in increased polymerase
activity of a highly pathogenic avian influenza strain upon
mammalian adaptation (Gabriel et al., 2005). We also
identified a novel PB2 residue important for HR activity, at
position 636, where phenylalanine improved activity in
mammalian cells in both virus backgrounds. This adds to a
cluster of HR-defining residues formed by the N-terminal
end of helix 5, the 627 loop and, now, b-sheet 1 (Fig. 3b;
structural nomenclature as defined by Tarendeau and
colleagues). F636 only occurs in a small minority of strains
in the sequence database (as of January 2011, 13 of 8371
unique viruses) which, when PR8 vaccine derivatives and
apparent instances of unnoticed PR8 contamination are
discounted, leaves two other human isolates from the
1930s, A/Alaska/35 and A/Henry/36, and one swine iso-
late, A/swine/Tennessee/79/1977 (H1N1), all with a 627K
residue. Therefore, either this polymorphism has not
persisted (perhaps through lack of selective advantage in
the presence of 627K) or it is a coincidental adaptation to
laboratory passage. However, tPB2 polymerases containing
it clearly displayed higher activity in human cells, so it will
be interesting to see whether the sequence variation
reoccurs in the future in 627E viruses.
In the swine-origin 2009 pandemic virus, residues 590/591
were identified as compensating positions for the lack of
627K (Mehle & Doudna, 2009; Yamada et al., 2010); these
residues lie close to position 588, which we found to be
important in tPB2 and PR8 settings. However, while it has
been proposed that the GQ590,591SR and Q591K poly-
morphisms function similarly to the E627K change in
altering the electrostatic charge on one face of the 627
domain (Mehle & Doudna, 2009; Tarendeau et al., 2008;
Yamada et al., 2010), our data argue against charge being
the only determinant of function. A comparison of the
predicted surface charge of the mammalian-active PR8 PB2
588, 636, 701 and tPB2 588, 636, 701 proteins with the
inactive tPB2 protein strongly suggests that no obligatory
correlation exists between electrostatic potential of the
domain and transcriptional activity in mammalian cells
(Fig. 3c). Thus, while we would not rule out an important
charge-dependent interaction with a host protein, this
seems unlikely to provide a full explanation of the role of
the 627 and NLS domains in host restriction. While a single
cellular protein whose binding is affected by the variety of
HR mutations located in the 627 and NLS domains as well
as elsewhere in PB2 is possible, multiple interactions
(perhaps competitive) with cellular factors seem equally
plausible. In favour of the former hypothesis, recent work
has found evidence that binding of importin a to the PB2
NLS domain is subject to steric interference from the 627
domain, albeit not subject to the identity of residue 627
(Boivin & Hart, 2011). Consistent with the latter hypo-
thesis, we have shown that a fragment of PB2 comprising
the NLS domain and part of the 627 domain mediates
competitive interactions with the viral NP and PB1 pro-
teins (Poole et al., 2004). Identification of the PB2-
interacting cellular protein(s) responsible for setting HR
will be key to resolving the mechanism of restriction.
METHODS
Cell culture, plasmids and DNA transfection. Human embryonic
kidney 293T and quail QT35 cells were transfected using
Lipofectamine 2000 according to the manufacturer’s instructions.
Plasmids for PB1–GFP or PB1–TAP, pcDNA PB1, PA and NP as well
as pPol-I-luc (with either a human or avian RNA pol I promoter) and
pDUAL PR8 PB2 have been described elsewhere (Benfield et al., 2008;
de Wit et al., 2004; Fodor & Smith, 2004; Mullin et al., 2004). pDUAL
plasmids for tPB2 and tPB2 627K were created by subcloning cDNA
copies of the segments (Howard et al., 2007) into the pDUAL vector
(de Wit et al., 2004). Site-directed mutagenesis was carried out using
mismatched PCR primers and Phusion polymerase according to
standard protocols. Primer sequences are available on request.
Protein and immunofluorescent analysis. Antibodies used were
mouse monoclonal anti-GFP JL-8 (Clontech), rat monoclonal c-
tubulin (YL1/2; AbD Serotec, MCA77G) and rabbit polyclonal anti-
PB2 (2N580; Carrasco et al., 2004). Western blots were developed using
secondary antibodies conjugated to IR Dye 680 or 800 (LiCor
Biosciences) and imaged on a LiCor Biosciences Odyssey instrument.
Cells were stained for immunofluorescence and imaged with a Leica
TCS SP confocal microscope as described previously (Wise et al., 2009).
Pull-down assays of TAP-tagged PB1 were performed as described by
Fodor & Smith (2004). RNP reconstitution (‘minireplicon’) assays
were carried out as described previously (Wise et al., 2009). For FRAP
analyses, 0.5 mg of each plasmid was transfected per dish.
FRAP microscopy. Cells seeded on 42 mm coverslips were
transferred to live cell chambers and maintained at 37 uC in
Leibovitz L-15 medium (Invitrogen). Images were captured on a
Zeiss LSM 510 confocal microscope using a 663 NA 1.4 objective.
Photobleaching was performed for 0.91 s using 100% power from a
30 mW 488 nm laser line running at 6.1 mA, within a 1.94 mm2
square (v2). Images were captured at 1% laser output at 0.39 s
intervals, obtaining 5126512 pixel images. Five pre-bleach and 70
post-bleach images were collected and the fluorescence intensities of
regions of interest were obtained using the LSM510 software. Values
were corrected by subtracting background fluorescence and then
adjusted for whole nucleus intensity to account for fluorescence loss
during the bleach period and acquisition photobleaching. Pre-bleach
intensity was set to 1 and immediate post-bleach to 0 to allow
comparison between samples. Data were fitted with a one-phase
association model [Y5Y0+(plateau2Y0)?(12e
2K?x)] using Prism
GraphPad [where K5ln(2)/t1/2 to yield t1/2 and plateau (Ymax)
values]. DCs were calculated from t1/2 values using the equation
DC53.694(v2/t1/2) according to the Axelrod model (Phair & Misteli,
2000). Student’s t-test (unpaired, two tailed; Prism GraphPad) was
used to assess statistical significance.
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